Noam Barda
Senior Academic
SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022 and 2023
Although a vaccine against SARS-CoV-2 Omicron-XBB.1.5 variant is available worldwide and recent infection is protective, the lack of recorded infection data highlights the need to assess variant-specific antibody neutralization levels. We analyzed IgG levels against receptor-binding domain–specific SARS-CoV-2 ancestral strain as a correlate for high neutralizing titers against XBB variants.
| Publication language | English |
| Pages | 1050-1052 |
| Journal | Emerging Infectious Diseases |
| Volume | 30 |
| Issue number | 5 |
| Publication status | Published - 01.05.2024 |
ASJC Scopus subject areas
Epidemiology
Microbiology (medical)
Infectious Diseases
